Prescription Drugs

7/26/07: Dodd Pledges to make Affordable Health Care, Financial Security a Priority in Congress

Joins with AARP, Business ROundtable, SEIU Partnership to support critical domestic issues

July 26, 2007


Senator Chris Dodd (D-CT), a senior member of the Senate Committee on Health, Education, Labor and Pensions, today pledged his commitment to working with his colleagues on both sides of the aisle to develop and implement policies that provide all Americans with access to quality, affordable health care and lifetime financial security by signing a pledge presented by Divided We Fail, a partnership formed by AARP, the Business Roundtable and Service Employees International Union (SEIU). 


1/30/07: Grassley, Dodd Seek Bold Reforms to Improve Drug Safety System

January 30, 2007


Renewing their commitment to ensuring FDA-approved drugs are safe once on the market, Sens. Chris Dodd (D-CT) and Chuck Grassley (R-IA) are reintroducing legislation to revamp and prioritize the post-market surveillance process within the Food and Drug Administration and to greatly expand public access to information about clinical trials regardless of the outcome of those trials through a clinical trials registry and results database.

 


11/08/06: Statement of CT Officials on Announced Closing of Bayer Pharmaceuticals

October 9, 2006

WEST HAVEN, Conn. - Connecticut Senators Christopher Dodd and Joseph Lieberman (D-CT), Congresswoman Rosa L. DeLauro (Conn.-3), Governor M. Jodi Rell and West Haven Mayor John M. Picard today issued the following statement on the closing of Bayer Pharmaceuticals North America.  Approximately 800 jobs-600 research and development jobs and 200 administrative and marketing jobs-at the West Haven facility will be affected by this closure.  

XML feed